PROVIDED.Marfan syndrome (MFS) is characterized by multiple disorders of connective tissue, includingaortic aneurysm, ectopia lentis, and sclerosis and kyphosis, caused by mutations in the fibrillin-1(Fbn-1) gene. Recent evidence indicates that the pathological sequellae are not caused only bychanges in the structural functions of Fbn-1 but also by alterations in the regulation of thebioavailability of signaling molecules, such as TGF-[3 and BMP. For example, thedevelopmental emphysema observed in mice with decreased Fbn-1 expression is related toheightened levels of active TGF-[51 in this tissue.This proposal contains two aims directed at validating the hypothesis that certain tissue changesin MFS result from altered interactions of TGF-I3 and BMPs.
In Aim 1, we will identify theactivator of latent TGF-I] in the lungs or aortas of mice with an Fbn-1 deficit. This will be doneusing either in vitro cell or tissue culture approaches and selective inhibitors of TGF-13generation or by a novel genetic screen we have developed for the identification of TGF-I]activators.
In Aim 2, we will characterize the role of Fbn-1 in modulating the activity of BMP-7.We will first develop a sensitive cell-based bioassay for BMP-7. We will next utilize this assayto determine whether and how BMP interaction with Fbn-1 affects latent BMP-7 activation,protects BMP-7 from inhibition, and focuses BMP-7 at sites of action. The results of theseexperiments will validate portions of the new mechanistic view of MFS and potentially identifytargets for therapies for MFS.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Program Projects (P01)
Project #
7P01AR049698-05
Application #
7685490
Study Section
Special Emphasis Panel (ZAR1)
Project Start
2008-07-01
Project End
2009-06-30
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
5
Fiscal Year
2008
Total Cost
$310,683
Indirect Cost
Name
Icahn School of Medicine at Mount Sinai
Department
Type
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
MacFarlane, Elena Gallo; Haupt, Julia; Dietz, Harry C et al. (2017) TGF-? Family Signaling in Connective Tissue and Skeletal Diseases. Cold Spring Harb Perspect Biol 9:
Bellini, C; Korneva, A; Zilberberg, L et al. (2016) Differential ascending and descending aortic mechanics parallel aneurysmal propensity in a mouse model of Marfan syndrome. J Biomech 49:2383-2389
Smaldone, Silvia; Ramirez, Francesco (2016) Fibrillin microfibrils in bone physiology. Matrix Biol 52-54:191-197
Lee, Jia-Jye; Galatioto, Josephine; Rao, Satish et al. (2016) Losartan Attenuates Degradation of Aorta and Lung Tissue Micromechanics in a Mouse Model of Severe Marfan Syndrome. Ann Biomed Eng 44:2994-3006
Sakai, Lynn Y; Keene, Douglas R; Renard, Marjolijn et al. (2016) FBN1: The disease-causing gene for Marfan syndrome and other genetic disorders. Gene 591:279-291
Walji, Tezin A; Turecamo, Sarah E; DeMarsilis, Antea J et al. (2016) Characterization of metabolic health in mouse models of fibrillin-1 perturbation. Matrix Biol 55:63-76
Robertson, Ian B; Rifkin, Daniel B (2016) Regulation of the Bioavailability of TGF-? and TGF-?-Related Proteins. Cold Spring Harb Perspect Biol 8:
Sengle, Gerhard; Sakai, Lynn Y (2015) The fibrillin microfibril scaffold: A niche for growth factors and mechanosensation? Matrix Biol 47:3-12
Zilberberg, Lior; Phoon, Colin K L; Robertson, Ian et al. (2015) Genetic analysis of the contribution of LTBP-3 to thoracic aneurysm in Marfan syndrome. Proc Natl Acad Sci U S A 112:14012-7
Robertson, Ian B; Horiguchi, Masahito; Zilberberg, Lior et al. (2015) Latent TGF-?-binding proteins. Matrix Biol 47:44-53

Showing the most recent 10 out of 78 publications